The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment

Clinical trial NCT03401957 · UNKNOWN

Trial details

NCT number: NCT03401957
Sponsor: National Health Research Institutes, Taiwan
Status: UNKNOWN
Study type: OBSERVATIONAL

Colorectal Cancer Drug Resistance Mass Spectrometry RAS-RAF Pathway Deregulation

Start date: 2018-01-01
Primary completion: 2022-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.